Bharat Biotech in tie-up with the US-based company FluGen and University of Wisconsin Madison to develop a vaccine named “Coro-Flu” to fight against COVID-19. CoroFlu will build on the backbone of FluGen’s flu vaccine candidate known as M2SR.
Click Here To Get Test Series For SBI PO 2020
The vaccine is being developed on the basis of FluGen’s flu vaccine candidate known as M2SR, a self-limited version of the influenza virus. It induces an immune response against the flu. The vaccine will be built by FluGen’s lab that inserts gene sequences from SARS-CoV-2, the novel coronavirus that causes the disease COVID-19 into M2SR so that the novel vaccine will also induce immunity against the coronavirus.
Important takeaways for all competitive exams:
Find More News Related to Agreements
In a monumental moment for South African cricket, the Proteas claimed their first-ever ICC trophy…
The ICC World Test Championship (WTC) is a premier biennial Test cricket tournament organized by…
Every year on June 15, the world comes together to observe World Elder Abuse Awareness…
Every year on June 14, countries around the globe observe World Blood Donor Day to…
In a historic development for cross-border sustainable finance, DFCC Bank PLC of Sri Lanka has…
In a significant step towards boosting indigenous defence capabilities, the Indian Army has successfully conducted…
![](data:image/svg+xml;charset=utf-8,<svg height="225px" width="300px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="34px" width="156px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
